← 產業報告目錄
Wearable Injectors and Connected Devices Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 133報告編號 APO-5457247053
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Wearable Injectors and Connected Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Wearable Injectors and Connected Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Wearable Injectors and Connected Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Wearable Injectors and Connected Devices include Roche, Ypsomed, West Pharma, United Therapeutics, Unilife Corporation, Sonceboz, ScPharmaceuticals, Owen Mumford and Noble International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Wearable Injectors and Connected Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Wearable Injectors and Connected Devices Market by Company
Roche
Ypsomed
West Pharma
United Therapeutics
Unilife Corporation
Sonceboz
ScPharmaceuticals
Owen Mumford
Noble International
Insulet
Gerresheimer
Enable Injections
Elcam Medical
Eitan Medical
CeQur
BD Medical
Amgen
Wearable Injectors and Connected Devices Segment by Type
Disposable
Reusable
Wearable Injectors and Connected Devices Segment by Application
Home Care Settings
Hospitals
Clinics
Others
Wearable Injectors and Connected Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Injectors and Connected Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Wearable Injectors and Connected Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Injectors and Connected Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Wearable Injectors and Connected Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Wearable Injectors and Connected Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Wearable Injectors and Connected Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Wearable Injectors and Connected Devices Market Size (2021-2032)
2.2.2 Global Wearable Injectors and Connected Devices Sales (2021-2032)
2.2.3 Global Wearable Injectors and Connected Devices Market Average Price (2021-2032)
2.3 Wearable Injectors and Connected Devices by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Disposable
2.3.3 Reusable
2.4 Wearable Injectors and Connected Devices by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Home Care Settings
2.4.3 Hospitals
2.4.4 Clinics
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Wearable Injectors and Connected Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Wearable Injectors and Connected Devices Sales (k units) of Manufacturers (2021-2026)
3.3 Global Wearable Injectors and Connected Devices Revenue of Manufacturers (2021-2026)
3.4 Global Wearable Injectors and Connected Devices Average Price by Manufacturers (2021-2026)
3.5 Global Wearable Injectors and Connected Devices Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Wearable Injectors and Connected Devices, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Wearable Injectors and Connected Devices, Product Type & Application
3.8 Global Manufacturers of Wearable Injectors and Connected Devices, Established Date
3.9 Global Wearable Injectors and Connected Devices Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Roche
4.1.1 Roche Company Information
4.1.2 Roche Business Overview
4.1.3 Roche Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Roche Wearable Injectors and Connected Devices Product Portfolio
4.1.5 Roche Recent Developments
4.2 Ypsomed
4.2.1 Ypsomed Company Information
4.2.2 Ypsomed Business Overview
4.2.3 Ypsomed Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Ypsomed Wearable Injectors and Connected Devices Product Portfolio
4.2.5 Ypsomed Recent Developments
4.3 West Pharma
4.3.1 West Pharma Company Information
4.3.2 West Pharma Business Overview
4.3.3 West Pharma Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.3.4 West Pharma Wearable Injectors and Connected Devices Product Portfolio
4.3.5 West Pharma Recent Developments
4.4 United Therapeutics
4.4.1 United Therapeutics Company Information
4.4.2 United Therapeutics Business Overview
4.4.3 United Therapeutics Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.4.4 United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
4.4.5 United Therapeutics Recent Developments
4.5 Unilife Corporation
4.5.1 Unilife Corporation Company Information
4.5.2 Unilife Corporation Business Overview
4.5.3 Unilife Corporation Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
4.5.5 Unilife Corporation Recent Developments
4.6 Sonceboz
4.6.1 Sonceboz Company Information
4.6.2 Sonceboz Business Overview
4.6.3 Sonceboz Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Sonceboz Wearable Injectors and Connected Devices Product Portfolio
4.6.5 Sonceboz Recent Developments
4.7 ScPharmaceuticals
4.7.1 ScPharmaceuticals Company Information
4.7.2 ScPharmaceuticals Business Overview
4.7.3 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.7.4 ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
4.7.5 ScPharmaceuticals Recent Developments
4.8 Owen Mumford
4.8.1 Owen Mumford Company Information
4.8.2 Owen Mumford Business Overview
4.8.3 Owen Mumford Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
4.8.5 Owen Mumford Recent Developments
4.9 Noble International
4.9.1 Noble International Company Information
4.9.2 Noble International Business Overview
4.9.3 Noble International Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Noble International Wearable Injectors and Connected Devices Product Portfolio
4.9.5 Noble International Recent Developments
4.10 Insulet
4.10.1 Insulet Company Information
4.10.2 Insulet Business Overview
4.10.3 Insulet Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Insulet Wearable Injectors and Connected Devices Product Portfolio
4.10.5 Insulet Recent Developments
4.11 Gerresheimer
4.11.1 Gerresheimer Company Information
4.11.2 Gerresheimer Business Overview
4.11.3 Gerresheimer Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
4.11.5 Gerresheimer Recent Developments
4.12 Enable Injections
4.12.1 Enable Injections Company Information
4.12.2 Enable Injections Business Overview
4.12.3 Enable Injections Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Enable Injections Wearable Injectors and Connected Devices Product Portfolio
4.12.5 Enable Injections Recent Developments
4.13 Elcam Medical
4.13.1 Elcam Medical Company Information
4.13.2 Elcam Medical Business Overview
4.13.3 Elcam Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
4.13.5 Elcam Medical Recent Developments
4.14 Eitan Medical
4.14.1 Eitan Medical Company Information
4.14.2 Eitan Medical Business Overview
4.14.3 Eitan Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
4.14.5 Eitan Medical Recent Developments
4.15 CeQur
4.15.1 CeQur Company Information
4.15.2 CeQur Business Overview
4.15.3 CeQur Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.15.4 CeQur Wearable Injectors and Connected Devices Product Portfolio
4.15.5 CeQur Recent Developments
4.16 BD Medical
4.16.1 BD Medical Company Information
4.16.2 BD Medical Business Overview
4.16.3 BD Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.16.4 BD Medical Wearable Injectors and Connected Devices Product Portfolio
4.16.5 BD Medical Recent Developments
4.17 Amgen
4.17.1 Amgen Company Information
4.17.2 Amgen Business Overview
4.17.3 Amgen Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Amgen Wearable Injectors and Connected Devices Product Portfolio
4.17.5 Amgen Recent Developments
5 Global Wearable Injectors and Connected Devices Market Scenario by Region
5.1 Global Wearable Injectors and Connected Devices Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Wearable Injectors and Connected Devices Sales by Region: 2021-2032
5.2.1 Global Wearable Injectors and Connected Devices Sales by Region: 2021-2026
5.2.2 Global Wearable Injectors and Connected Devices Sales by Region: 2027-2032
5.3 Global Wearable Injectors and Connected Devices Revenue by Region: 2021-2032
5.3.1 Global Wearable Injectors and Connected Devices Revenue by Region: 2021-2026
5.3.2 Global Wearable Injectors and Connected Devices Revenue by Region: 2027-2032
5.4 North America Wearable Injectors and Connected Devices Market Facts & Figures by Country
5.4.1 North America Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Wearable Injectors and Connected Devices Sales by Country (2021-2032)
5.4.3 North America Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Wearable Injectors and Connected Devices Market Facts & Figures by Country
5.5.1 Europe Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Wearable Injectors and Connected Devices Sales by Country (2021-2032)
5.5.3 Europe Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Wearable Injectors and Connected Devices Market Facts & Figures by Country
5.6.1 Asia Pacific Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2021-2032)
5.6.3 Asia Pacific Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Wearable Injectors and Connected Devices Market Facts & Figures by Country
5.7.1 South America Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Wearable Injectors and Connected Devices Sales by Country (2021-2032)
5.7.3 South America Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Wearable Injectors and Connected Devices Market Facts & Figures by Country
5.8.1 Middle East and Africa Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2021-2032)
5.8.3 Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Wearable Injectors and Connected Devices Sales by Type (2021-2032)
6.1.1 Global Wearable Injectors and Connected Devices Sales by Type (2021-2032) & (k units)
6.1.2 Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2032)
6.2 Global Wearable Injectors and Connected Devices Revenue by Type (2021-2032)
6.2.1 Global Wearable Injectors and Connected Devices Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2032)
6.3 Global Wearable Injectors and Connected Devices Price by Type (2021-2032)
7 Segment by Application
7.1 Global Wearable Injectors and Connected Devices Sales by Application (2021-2032)
7.1.1 Global Wearable Injectors and Connected Devices Sales by Application (2021-2032) & (k units)
7.1.2 Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2032)
7.2 Global Wearable Injectors and Connected Devices Revenue by Application (2021-2032)
7.2.1 Global Wearable Injectors and Connected Devices Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2032)
7.3 Global Wearable Injectors and Connected Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Wearable Injectors and Connected Devices Value Chain Analysis
8.1.1 Wearable Injectors and Connected Devices Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Wearable Injectors and Connected Devices Production Mode & Process
8.2 Wearable Injectors and Connected Devices Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Wearable Injectors and Connected Devices Distributors
8.2.3 Wearable Injectors and Connected Devices Customers
9 Global Wearable Injectors and Connected Devices Analyzing Market Dynamics
9.1 Wearable Injectors and Connected Devices Industry Trends
9.2 Wearable Injectors and Connected Devices Industry Drivers
9.3 Wearable Injectors and Connected Devices Industry Opportunities and Challenges
9.4 Wearable Injectors and Connected Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Wearable Injectors and Connected Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Wearable Injectors and Connected Devices Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Wearable Injectors and Connected Devices Revenue of Manufacturers (2021-2026)
Table 9. Global Wearable Injectors and Connected Devices Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Wearable Injectors and Connected Devices Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Wearable Injectors and Connected Devices Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Wearable Injectors and Connected Devices, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Wearable Injectors and Connected Devices, Product Type & Application
Table 14. Global Wearable Injectors and Connected Devices Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Wearable Injectors and Connected Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Roche Company Information
Table 19. Roche Business Overview
Table 20. Roche Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Roche Wearable Injectors and Connected Devices Product Portfolio
Table 22. Roche Recent Developments
Table 23. Ypsomed Company Information
Table 24. Ypsomed Business Overview
Table 25. Ypsomed Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Ypsomed Wearable Injectors and Connected Devices Product Portfolio
Table 27. Ypsomed Recent Developments
Table 28. West Pharma Company Information
Table 29. West Pharma Business Overview
Table 30. West Pharma Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. West Pharma Wearable Injectors and Connected Devices Product Portfolio
Table 32. West Pharma Recent Developments
Table 33. United Therapeutics Company Information
Table 34. United Therapeutics Business Overview
Table 35. United Therapeutics Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
Table 37. United Therapeutics Recent Developments
Table 38. Unilife Corporation Company Information
Table 39. Unilife Corporation Business Overview
Table 40. Unilife Corporation Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
Table 42. Unilife Corporation Recent Developments
Table 43. Sonceboz Company Information
Table 44. Sonceboz Business Overview
Table 45. Sonceboz Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Sonceboz Wearable Injectors and Connected Devices Product Portfolio
Table 47. Sonceboz Recent Developments
Table 48. ScPharmaceuticals Company Information
Table 49. ScPharmaceuticals Business Overview
Table 50. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
Table 52. ScPharmaceuticals Recent Developments
Table 53. Owen Mumford Company Information
Table 54. Owen Mumford Business Overview
Table 55. Owen Mumford Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
Table 57. Owen Mumford Recent Developments
Table 58. Noble International Company Information
Table 59. Noble International Business Overview
Table 60. Noble International Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Noble International Wearable Injectors and Connected Devices Product Portfolio
Table 62. Noble International Recent Developments
Table 63. Insulet Company Information
Table 64. Insulet Business Overview
Table 65. Insulet Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Insulet Wearable Injectors and Connected Devices Product Portfolio
Table 67. Insulet Recent Developments
Table 68. Gerresheimer Company Information
Table 69. Gerresheimer Business Overview
Table 70. Gerresheimer Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
Table 72. Gerresheimer Recent Developments
Table 73. Enable Injections Company Information
Table 74. Enable Injections Business Overview
Table 75. Enable Injections Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Enable Injections Wearable Injectors and Connected Devices Product Portfolio
Table 77. Enable Injections Recent Developments
Table 78. Elcam Medical Company Information
Table 79. Elcam Medical Business Overview
Table 80. Elcam Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
Table 82. Elcam Medical Recent Developments
Table 83. Eitan Medical Company Information
Table 84. Eitan Medical Business Overview
Table 85. Eitan Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
Table 87. Eitan Medical Recent Developments
Table 88. CeQur Company Information
Table 89. CeQur Business Overview
Table 90. CeQur Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. CeQur Wearable Injectors and Connected Devices Product Portfolio
Table 92. CeQur Recent Developments
Table 93. BD Medical Company Information
Table 94. BD Medical Business Overview
Table 95. BD Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. BD Medical Wearable Injectors and Connected Devices Product Portfolio
Table 97. BD Medical Recent Developments
Table 98. Amgen Company Information
Table 99. Amgen Business Overview
Table 100. Amgen Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. Amgen Wearable Injectors and Connected Devices Product Portfolio
Table 102. Amgen Recent Developments
Table 103. Global Wearable Injectors and Connected Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 104. Global Wearable Injectors and Connected Devices Sales by Region (2021-2026) & (k units)
Table 105. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2021-2026)
Table 106. Global Wearable Injectors and Connected Devices Sales by Region (2027-2032) & (k units)
Table 107. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2027-2032)
Table 108. Global Wearable Injectors and Connected Devices Revenue by Region (2021-2026) & (US$ Million)
Table 109. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2021-2026)
Table 110. Global Wearable Injectors and Connected Devices Revenue by Region (2027-2032) & (US$ Million)
Table 111. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2027-2032)
Table 112. North America Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. North America Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 114. North America Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 115. North America Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million)
Table 116. North America Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million)
Table 117. Europe Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Europe Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 119. Europe Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 120. Europe Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million)
Table 121. Europe Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million)
Table 122. Asia Pacific Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 124. Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 125. Asia Pacific Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million)
Table 126. Asia Pacific Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million)
Table 127. South America Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. South America Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 129. South America Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 130. South America Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million)
Table 131. South America Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million)
Table 132. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 134. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 135. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million)
Table 136. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million)
Table 137. Global Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units)
Table 138. Global Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units)
Table 139. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2026)
Table 140. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2027-2032)
Table 141. Global Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (US$ Million)
Table 142. Global Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (US$ Million)
Table 143. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2026)
Table 144. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2027-2032)
Table 145. Global Wearable Injectors and Connected Devices Price by Type (2021-2026) & (USD/unit)
Table 146. Global Wearable Injectors and Connected Devices Price by Type (2027-2032) & (USD/unit)
Table 147. Global Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units)
Table 148. Global Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units)
Table 149. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2026)
Table 150. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2027-2032)
Table 151. Global Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (US$ Million)
Table 152. Global Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (US$ Million)
Table 153. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2026)
Table 154. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2027-2032)
Table 155. Global Wearable Injectors and Connected Devices Price by Application (2021-2026) & (USD/unit)
Table 156. Global Wearable Injectors and Connected Devices Price by Application (2027-2032) & (USD/unit)
Table 157. Key Raw Materials
Table 158. Raw Materials Key Suppliers
Table 159. Wearable Injectors and Connected Devices Distributors List
Table 160. Wearable Injectors and Connected Devices Customers List
Table 161. Wearable Injectors and Connected Devices Industry Trends
Table 162. Wearable Injectors and Connected Devices Industry Drivers
Table 163. Wearable Injectors and Connected Devices Industry Restraints
Table 164. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Wearable Injectors and Connected Devices Product Image
Figure 5. Global Wearable Injectors and Connected Devices Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Wearable Injectors and Connected Devices Market Size (2021-2032) & (US$ Million)
Figure 7. Global Wearable Injectors and Connected Devices Sales (2021-2032) & (k units)
Figure 8. Global Wearable Injectors and Connected Devices Average Price (USD/unit) & (2021-2032)
Figure 9. Disposable Product Image
Figure 10. Reusable Product Image
Figure 11. Home Care Settings Product Image
Figure 12. Hospitals Product Image
Figure 13. Clinics Product Image
Figure 14. Others Product Image
Figure 15. Global Wearable Injectors and Connected Devices Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Wearable Injectors and Connected Devices, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Wearable Injectors and Connected Devices Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Wearable Injectors and Connected Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Wearable Injectors and Connected Devices Sales by Region in 2025
Figure 21. Global Wearable Injectors and Connected Devices Revenue by Region in 2025
Figure 22. North America Wearable Injectors and Connected Devices Market Size by Country in 2025
Figure 23. North America Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 24. North America Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032)
Figure 25. United States Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Mexico Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Europe Wearable Injectors and Connected Devices Market Size by Country in 2025
Figure 29. Europe Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 30. Europe Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032)
Figure 31. Germany Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. France Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. U.K. Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Italy Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Russia Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Spain Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Netherlands Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Switzerland Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Sweden Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Poland Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Asia Pacific Wearable Injectors and Connected Devices Market Size by Country in 2025
Figure 42. Asia Pacific Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 43. Asia Pacific Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032)
Figure 44. China Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Japan Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South Korea Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. India Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Australia Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Taiwan Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. South America Wearable Injectors and Connected Devices Market Size by Country in 2025
Figure 53. South America Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 54. South America Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032)
Figure 55. Brazil Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Argentina Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Chile Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Middle East and Africa Wearable Injectors and Connected Devices Market Size by Country in 2025
Figure 59. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 60. Middle East and Africa Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032)
Figure 61. Egypt Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. South Africa Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Israel Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Türkiye Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. GCC Countries Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2032)
Figure 67. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2032)
Figure 68. Global Wearable Injectors and Connected Devices Price (USD/unit) by Type (2021-2032)
Figure 69. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2032)
Figure 70. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2032)
Figure 71. Global Wearable Injectors and Connected Devices Price (USD/unit) by Application (2021-2032)
Figure 72. Wearable Injectors and Connected Devices Value Chain
Figure 73. Wearable Injectors and Connected Devices Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Wearable Injectors and Connected Devices Industry Opportunities and Challenges
提及公司
RocheYpsomedWest PharmaUnited TherapeuticsUnilife CorporationSoncebozScPharmaceuticalsOwen MumfordNoble InternationalInsuletGerresheimerEnable InjectionsElcam MedicalEitan MedicalCeQurBD MedicalAmgen
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們